Dean Elterman

3.7k total citations
232 papers, 2.0k citations indexed

About

Dean Elterman is a scholar working on Urology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Dean Elterman has authored 232 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Urology, 113 papers in Pulmonary and Respiratory Medicine and 100 papers in Rheumatology. Recurrent topics in Dean Elterman's work include Urinary Bladder and Prostate Research (162 papers), Prostate Cancer Diagnosis and Treatment (108 papers) and Pelvic floor disorders treatments (89 papers). Dean Elterman is often cited by papers focused on Urinary Bladder and Prostate Research (162 papers), Prostate Cancer Diagnosis and Treatment (108 papers) and Pelvic floor disorders treatments (89 papers). Dean Elterman collaborates with scholars based in Canada, United States and United Kingdom. Dean Elterman's co-authors include Kevin C. Zorn, Bilal Chughtai, Naeem Bhojani, David‐Dan Nguyen, Jack Barkin, Vincent Misraï, Andrew E. MacNeily, Alexis E. Te, Steven A. Kaplan and Jaspreet S. Sandhu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Urology and European Urology.

In The Last Decade

Dean Elterman

202 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dean Elterman Canada 24 1.3k 917 859 333 231 232 2.0k
Lori B. Lerner United States 19 1.1k 0.9× 878 1.0× 612 0.7× 206 0.6× 176 0.8× 55 1.8k
Jennifer T. Anger United States 29 1.3k 1.0× 177 0.2× 2.1k 2.4× 1.2k 3.7× 76 0.3× 149 2.9k
Patrick Jones United Kingdom 25 466 0.4× 1.3k 1.4× 264 0.3× 170 0.5× 43 0.2× 83 1.7k
Kourosh Afshar Canada 21 613 0.5× 343 0.4× 248 0.3× 460 1.4× 10 0.0× 79 1.4k
Vera Hermina Kalika Koch Brazil 22 153 0.1× 247 0.3× 130 0.2× 178 0.5× 130 0.6× 104 1.5k
Laura Edwards United States 16 100 0.1× 341 0.4× 69 0.1× 131 0.4× 214 0.9× 38 1.3k
Cynthia D. Downard United States 25 147 0.1× 698 0.8× 43 0.1× 1.3k 3.9× 39 0.2× 63 2.1k
Paul L. Ogburn United States 26 136 0.1× 186 0.2× 62 0.1× 465 1.4× 100 0.4× 85 1.9k
Luís Cláudio Lemos Correia Brazil 20 73 0.1× 170 0.2× 78 0.1× 278 0.8× 68 0.3× 126 1.4k
C. Andrew Combs United States 27 52 0.0× 174 0.2× 198 0.2× 698 2.1× 298 1.3× 110 3.6k

Countries citing papers authored by Dean Elterman

Since Specialization
Citations

This map shows the geographic impact of Dean Elterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean Elterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean Elterman more than expected).

Fields of papers citing papers by Dean Elterman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dean Elterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean Elterman. The network helps show where Dean Elterman may publish in the future.

Co-authorship network of co-authors of Dean Elterman

This figure shows the co-authorship network connecting the top 25 collaborators of Dean Elterman. A scholar is included among the top collaborators of Dean Elterman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dean Elterman. Dean Elterman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaplan, Steven A. & Dean Elterman. (2025). New BPH therapy classification: what really FITs?. Prostate Cancer and Prostatic Diseases. 29(1). 98–99.
2.
Nguyen, Vi, Clara Cerrato, Dean Elterman, et al.. (2025). Minimal Approach to Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia: Is Less More?. Urology. 202. 97–102.
3.
Alberti, Andrea, Francesca Conte, Rossella Nicoletti, et al.. (2025). Endoscopic enucleation vs. robot-assisted simple prostatectomy for large prostates: a systematic review and meta-analysis of patients’ perspectives. Prostate Cancer and Prostatic Diseases. 29(1). 73–82. 1 indexed citations
4.
Kaplan, Steven A., Ronald P. Kaufman, Dean Elterman, Bilal Chughtai, & Claus G. Roehrborn. (2025). Extended LUTS medication use following BPH surgical treatment: a US healthcare claims analysis. Prostate Cancer and Prostatic Diseases. 28(4). 913–917. 1 indexed citations
5.
Franco, Antonio, Francesco Ditonno, Eugenio Bologna, et al.. (2025). Systematic Review and Pooled Analysis of Functional and Sexual Outcomes of Minimally Invasive Surgical Treatments for Benign Prostatic Obstruction. European Urology. 89(4). 318–331. 1 indexed citations
7.
Gilling, Peter, Peter Chin, Paul Anderson, et al.. (2024). MP27-01 24-MONTH OUTCOMES FROM THE ZEST PILOT STUDIES OF THE ZENFLOW SPRING SYSTEM FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH). The Journal of Urology. 211(5S).
8.
Elterman, Dean, et al.. (2024). Evaluation of proudP. Canadian Urological Association Journal. 19(1). E50–E54. 1 indexed citations
9.
Matthew, A., et al.. (2024). (079) IMPLEMENTATION OF A HYBRID VIRTUAL/IN-PERSON SEXUAL HEALTH CLINIC IN A HIGH- VOLUME CANCER CENTRE. The Journal of Sexual Medicine. 21(Supplement_6).
10.
Elterman, Dean, Premal Patel, Daniel Costa, et al.. (2024). An analysis of benign prostatic hyperplasia surgical treatment reimbursement trends across Canada. Canadian Urological Association Journal. 18(8). 268–273. 2 indexed citations
11.
Secco, Silvia, et al.. (2024). Can ChatGPT provide high-quality patient information on male lower urinary tract symptoms suggestive of benign prostate enlargement?. Prostate Cancer and Prostatic Diseases. 28(1). 167–172. 6 indexed citations
12.
Sze, Christina, et al.. (2024). Saw Palmetto Treatment for Prostatitis: A Systematic Review of the Literature. JU Open Plus. 2(2).
13.
Hinata, Nobuyuki, Raizo Yamaguchi, Daisuke Katsura, et al.. (2024). AQUABEAM robotic system use‐results survey: Aquablation for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia in the Japanese Population. International Journal of Urology. 32(3). 308–313. 1 indexed citations
14.
Ibrahim, Ahmed, et al.. (2023). Peri-prostatic nerve block using Clarius EC7 HD₃ handheld ultrasound guidance.. PubMed. 30(6). 11741–11746. 1 indexed citations
15.
Nedbal, Carlotta, Daniele Castellani, Virgilio De Stefano, et al.. (2023). Will Aquablation Be the New Benchmark for Robotic Minimally Invasive Surgical Treatment for Benign Prostatic Hyperplasia?. European Urology Focus. 10(4). 581–593. 3 indexed citations
16.
Sze, Christina, et al.. (2022). Use of the penile cuff test to diagnose bladder outlet obstruction: A systematic review and meta‐analysis. LUTS Lower Urinary Tract Symptoms. 14(5). 318–328. 1 indexed citations
17.
Elterman, Dean, Eric Margolis, Christopher D. Betts, et al.. (2022). Prospective, multicenter study to evaluate performance and safety of a re‐engineered temporary lead for InterStim™ therapy evaluation. Neurourology and Urodynamics. 41(8). 1731–1738. 1 indexed citations
18.
Sze, Christina, Ahra Cho, Jialin Mao, et al.. (2022). Role of Pessaries in the Treatment of Pelvic Organ Prolapse. Obstetrics and Gynecology. 140(4). 613–622. 11 indexed citations
19.
Nguyen, David‐Dan, Jethro C.C. Kwong, Bilal Chughtai, et al.. (2022). Clinical Applications of Machine Learning for Urolithiasis and Benign Prostatic Hyperplasia: A Systematic Review. Journal of Endourology. 37(4). 474–494. 7 indexed citations
20.
Lee, Richard K., Bilal Chughtai, Dean Elterman, et al.. (2013). Comparison of 80 W versus 120 W 532 nm Laser Prostatectomy for BPH. Open Journal of Urology. 3(1). 1–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026